John Wiley & Sons, Inc.: Form 10-Q for the period ended Oct 31, 2023
Filed with the SEC on Dec 7, 2023 and accepted by EDGAR at Dec 7, 2023, 12:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-08-01 to 2023-10-31 | $492.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-05-01 to 2023-10-31 | $943.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-08-01 to 2023-10-31 | $155.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-05-01 to 2023-10-31 | $312.7m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-08-01 to 2023-10-31 | $252.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-05-01 to 2023-10-31 | $508.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-08-01 to 2023-10-31 | $46.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-05-01 to 2023-10-31 | $29.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-08-01 to 2023-10-31 | $12.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-05-01 to 2023-10-31 | $24.3m | us-gaap:InterestExpense |
| Income tax | 3 months2023-08-01 to 2023-10-31 | −$2.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-05-01 to 2023-10-31 | −$17.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-08-01 to 2023-10-31 | −$19.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-05-01 to 2023-10-31 | −$111.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-08-01 to 2023-10-31 | −$0.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-05-01 to 2023-10-31 | −$2.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-08-01 to 2023-10-31 | −$0.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-05-01 to 2023-10-31 | −$2.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-08-01 to 2023-10-31 | 55,102,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-05-01 to 2023-10-31 | 55,186,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-05-01 to 2023-10-31 | −$83.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-05-01 to 2023-10-31 | $40.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-05-01 to 2023-10-31 | $38.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2023-05-01 to 2023-10-31 | $22.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-10-31 | $83.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-10-31 | $425.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-10-31 | $2.78bn | us-gaap:Assets |
| Current liabilities | At period end2023-10-31 | $610.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-10-31 | $1.91bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-10-31 | $937.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-10-31 | $5.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-10-31 | $867.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000107140-23-000239. Last ingested by Listed: Nov 3, 2026, 22:24 ET. Listed shows no prices and gives no investment advice.